Literature DB >> 19903101

Individual and combined effects of mesenchymal stromal cells and recombinant stimulatory cytokines on the in vitro growth of primitive hematopoietic cells from human umbilical cord blood.

Patricia Flores-Guzmán1, Eugenia Flores-Figueroa, Juan J Montesinos, Guadalupe Martínez-Jaramillo, Veronica Fernández-Sánchez, Ignacio Valencia-Plata, Guadalupe Alarcón-Santos, Hector Mayani.   

Abstract

BACKGROUND AIMS: We have previously characterized the in vitro growth of two cord blood-derived hematopoietic cell populations in liquid cultures supplemented with recombinant cytokines. In the present study, we assessed the effects of bone marrow-derived mesenchymal stromal cells (MSC) on the growth of such cells.
METHODS: CD34(+) CD38(+) Lin(-) and CD34(+) CD38(-) Lin(-) cells were obtained by negative selection, and cultured in the presence of marrow-derived MSC and/or early- and late-acting cytokines. Hematopoietic cell growth was assessed throughout a 30-day culture period.
RESULTS: In the presence of MSC alone, both populations showed significant proliferation. Direct contact between MSC and CD34(+) cells was fundamental for optimal growth, especially for CD34(+) CD38(-) Lin(-) cells. In the presence of early-acting cytokines alone, cell growth was significantly higher than in cultures established with MSC but no cytokines. In cultures containing both MSC and early-acting cytokines, a further stimulation was observed only for CD34(+) CD38(-) Lin(-) cells. The cytokine cocktail containing both early- and late-acting cytokines was significantly more potent at inducing hematopoietic cell growth than the early-acting cytokine cocktail. When cultures were supplemented with early- and late-acting cytokines, MSC had no further effect on the growth of hematopoietic cells.
CONCLUSIONS: MSC seem to play a key role, particularly on more primitive (CD34(+) CD38(-) Lin(-)) cells, only in the absence of cytokines or the presence of early-acting cytokines. When both early- and late-acting cytokines are present in culture, MSC seem to be unnecessary for optimal development of CFC and CD34(+) cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19903101     DOI: 10.3109/14653240903180076

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  12 in total

Review 1.  Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine.

Authors:  Patricia Flores-Guzmán; Verónica Fernández-Sánchez; Hector Mayani
Journal:  Stem Cells Transl Med       Date:  2013-10-07       Impact factor: 6.940

2.  Intramarrow injection of beta-catenin-activated, but not naive mesenchymal stromal cells stimulates self-renewal of hematopoietic stem cells in bone marrow.

Authors:  Ji Yeon Ahn; Gyeongsin Park; Jae Seung Shim; Jong Wook Lee; Il Hoan Oh
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

3.  In vitro evidence of the presence of mesenchymal stromal cells in cervical cancer and their role in protecting cancer cells from cytotoxic T cell activity.

Authors:  Juan J Montesinos; María de L Mora-García; Héctor Mayani; Eugenia Flores-Figueroa; Rosario García-Rocha; Guadalupe R Fajardo-Orduña; Marta E Castro-Manrreza; Benny Weiss-Steider; Alberto Monroy-García
Journal:  Stem Cells Dev       Date:  2013-06-14       Impact factor: 3.272

Review 4.  Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.

Authors:  Melania Lo Iacono; Rita Anzalone; Giampiero La Rocca; Elena Baiamonte; Aurelio Maggio; Santina Acuto
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

5.  Perivascular support of human hematopoietic stem/progenitor cells.

Authors:  Mirko Corselli; Chee Jia Chin; Chintan Parekh; Arineh Sahaghian; Wenyuan Wang; Shundi Ge; Denis Evseenko; Xiaoyan Wang; Elisa Montelatici; Lorenza Lazzari; Gay M Crooks; Bruno Péault
Journal:  Blood       Date:  2013-02-14       Impact factor: 22.113

6.  Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells).

Authors:  Simone Perucca; Andrea Di Palma; Pier Paolo Piccaluga; Claudia Gemelli; Elisa Zoratti; Giulio Bassi; Edoardo Giacopuzzi; Andrea Lojacono; Giuseppe Borsani; Enrico Tagliafico; Maria Teresa Scupoli; Simona Bernardi; Camilla Zanaglio; Federica Cattina; Valeria Cancelli; Michele Malagola; Mauro Krampera; Mirella Marini; Camillo Almici; Sergio Ferrari; Domenico Russo
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

7.  Human Mesenchymal Stem/Stromal Cells from Umbilical Cord Blood and Placenta Exhibit Similar Capacities to Promote Expansion of Hematopoietic Progenitor Cells In Vitro.

Authors:  Guadalupe R Fajardo-Orduña; Héctor Mayani; Patricia Flores-Guzmán; Eugenia Flores-Figueroa; Erika Hernández-Estévez; Marta Castro-Manrreza; Patricia Piña-Sánchez; Lourdes Arriaga-Pizano; Alejandro Gómez-Delgado; Guadalupe Alarcón-Santos; Odette Balvanera-Ortíz; Juan J Montesinos
Journal:  Stem Cells Int       Date:  2017-11-09       Impact factor: 5.443

8.  Lymphoid progenitor cells from childhood acute lymphoblastic leukemia are functionally deficient and express high levels of the transcriptional repressor Gfi-1.

Authors:  Jessica Purizaca; Adriana Contreras-Quiroz; Elisa Dorantes-Acosta; Eduardo Vadillo; Lourdes Arriaga-Pizano; Silvestre Fuentes-Figueroa; Horacio Villagomez-Barragán; Patricia Flores-Guzmán; Antonio Alvarado-Moreno; Hector Mayani; Isaura Meza; Rosaura Hernandez; Sara Huerta-Yepez; Rosana Pelayo
Journal:  Clin Dev Immunol       Date:  2013-10-03

Review 9.  The Differentiation Balance of Bone Marrow Mesenchymal Stem Cells Is Crucial to Hematopoiesis.

Authors:  Jiang Wu; Weiwei Zhang; Qian Ran; Yang Xiang; Jiang F Zhong; Shengwen Calvin Li; Zhongjun Li
Journal:  Stem Cells Int       Date:  2018-04-03       Impact factor: 5.443

10.  Mesenchymal stem cells promote a primitive phenotype CD34+c-kit+ in human cord blood-derived hematopoietic stem cells during ex vivo expansion.

Authors:  Viviana M Rodríguez-Pardo; Jean Paul Vernot
Journal:  Cell Mol Biol Lett       Date:  2012-10-27       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.